U.S. Fertility Clinics & Infertility Services: 2018 Industry Analysis

News provided by

Dec 10, 2018, 11:15 ET

DUBLIN, Dec. 10, 2018 /PRNewswire/ --

The "U.S. Fertility Clinics & Infertility Services: An Industry Analysis" report has been added to ResearchAndMarkets.com's offering.

This analysis by the publisher examines the controversial $5.8 billion infertility services/fertility clinics growth industry.

This loosely regulated baby business has weathered the last recession pretty well and has grown strongly since 2014, boosted both by demand domestically and via medical tourism patients from Europe and China. This largely untapped market is characterized by favorable demographics and a strong economy. Venture capital firms are eyeing the potential.

ART (assisted reproductive technology) now produces more than 50,000 babies per year in the U.S. via 263,000 IVF procedures, and demand is growing from the ranks of 7+ million infertile women, many of which delayed childbearing due to careers. Foreigners and gay couples are two other areas of growth.

There are about 480 U.S. fertility clinics, 100+ sperm banks, an unknown number of egg donors, and 1,700 reproductive endocrinologists competing for the business, which is lucrative. In addition, the global market for fertility drugs is just under $1 billion. Only one large chain, IntegraMed, exists, as most programs are run by small MD practices or are part of a hospital or University. The market is fragmented, served by mostly small regional clinics.

This 3rd edition study examines the nature/evolution of the business, national receipts/growth from 1988 to 2023 forecast, infertile customer demographics, key industry trends, industry regulation, pricing, industry consolidation, insurance coverage, ethical issues, and more. Contains results of the latest (2015-2016) CDC ART survey national data, with IVF success rates and long-term trends, as well as European ART cycles survey data. The report also examines the nature/size of the U.S. sperm banks, egg donors, and fertility drugs markets, and surrogacy programs.

Competitor Profiles

Cryos International
California Cryobank
Resolve
Allan Guttmacher Institute
Genetics and IVF Institute
IntegraMed America

Key Topics Covered

1. Introduction

2. Report Scope & Methodology, Sources used

3. Executive Overview of Major Findings

4. Nature & Structure of the Industry

Definition of market segments (IVF ART clinics, sperm banks, egg donors, fertility drugs, surrogacy programs, surgeries)
Industry evolution - when clinics first appeared
Market demand and potential: Number and percent of women of childbearing age infertile, increase in IVF procedures from 1987-2016, reasons for continued growth, past estimates of industry size
Insurance coverage: typical fees and client affordability, state mandated coverage, financing
Causes of infertility: discussion of main reasons for infertility in men and women, treatment methods (HSG procedures, lap and dye procedures - description, cost, estimated number of procedures). Tubal reversal surgeries (description of, success rates, costs, percent of women having procedure, estimated number of surgeries).
IVF procedures: discussion of procedure, cost. GIFT procedures: discussion of procedure, cost, number of procedures.

5. Customer Demographics

U.S. birth & fertility rates: data - report highlights regarding number of births, total births in the United States, crude birth rate, general fertility rate
Americans' use of fertility services: demographics and characteristics
Chinese couples demand for U.S. fertility services, discussion, IVF tourism trends by European couples
Summary and discussion of number and percent of infertile female population in the U.S. (U.S.
Census Bureau data, American Society for Reproductive Medicine)
Reasons why the market is largely untapped: how price deters most candidates
Delayer boom: more educated women have children later in life

Tables:

Number of U.S. births and general fertility rate

6. Industry Size and Growth

Summary and Analysis; historical estimates of industry size - 1988,1995, 2000 (gov't. & private sources)
The publisher's estimate of mkt. size in 1999, by diagnostic procedure, IVF, drugs, surgeries
Harvard Business School estimate for 2004
Discussion of no. of IVF clinics 1985-2016, avg. revenues, value of this market segment 2014-2016 market performance: estimated growth, pricing, IntegraMed
revenues.
2017 & 2018 estimates/projections -: discussion of key factors: Chinese medial tourists, domestic econom small clinics vs. IntegraMed performance, user demographics, publisher forecast of ART cycles volum$ value of the market. 2023 Forecast: Factors affecting current and future industry growth: IVF tourism, economic Recovery/recession probability, public policy, improved success rates, gay/lesbian use of IVF, etc.
Status of the European and Chinese Markets, report of ESHRE, IVF volume, percent distribution of IVF vs. ICSI (1997-2009), which nations infertile couples come from, reasons, reimbursement
ESHRE headquarters address.

Tables:

Historical $ Size of fertility services industry - 1995-2018: diagnostic & therapeutic procedures (no. performed, avg. cost, estd. $ value: office consultations, semen analysis, hormone evaluations, tubal reversals, IVF & GIFT procedures, fertility drugs, donor eggs, donor sperm, surrogacies)
Size of fertility treatment industry: 2004 (Debora Spar, Harvard Business School book)
No. of clinics, ART procedures performed, revenues: 1985-2016 (CDC data)
Top 21 U.S. fertility clinics, by no. of IVF cycles performed and revenues: 2016
Top 21 U.S. fertility clinics, by no. of IVF cycles performed and revenues: 2014
No. of ART cycles performed, % change: 1997-2023 forecast
Demand for assisted reproductive technology in China infographic
Size of fertility services industry - 2012 vs. 2008: diagnostic & therapeutic procedures (no. performed, avg. cost, estd. $ value) - breakdowns as above
Estimated historical size of mkt., by segment: 1988, 1995, 2000, 2004, 2006, 2008, 2012
No. of ART cycles performed in various European nations: 1997-2009.

7. Sperm Banks and Egg Donor Markets, Surrogacy

Sperm Banks
Summary and discussion: number of U.S. sperm banks, typical fees, main activities
How the process works: requirements and screening of sperm donors, who typical donors are, fees, contracts
Estimated value of the market: 2004 - 2023 F
Market trends - why market is flat, gray market sperm
Major competitor Profiles: Cryos International Sperm Bank (Denmark), California Cryobank - typical procedures and requirements of donors, findings of phone interview

8. Egg Donor Market

Discussion of egg donors, frozen embryo replacement, fees, who they are, differentiated pricing structure, estimated market value: why this is a strong growth market, foreign demand, market size: 2004-2023 Forecast.
Analysis of egg donation data from 2015 CDC ART report, the publisher's mkt. size estimates for 2016, 2018, 2023
Discussion of European mkt. report about social egg freezers, low rate of thawing.

9. Surrogacy Programs: Discussion of the need for it, mkt. size, fees, etc.

10. The Fertility Drugs Market

Summary of the U.S. & global fertility drugs market: estimated size, key competitors (Organon, Merck Serono, Ferring)
Outlook and sales results from Merck's annual reports for North America versus rest of world, outlook for Gonal-f and Pergoveris
Estimated market share for Merck Serono, $ sales
Discussion of increase in illicit drug market developing between buyers and sellers
The publisher estimates of fertility drug sales: 1995 - 2023 F, five year forecast

11. Findings of 2015-2016 CDC ART Surveys on Assisted Reproductive Technology - Success Rates

Findings of 2015 survey & preliminary. 2016 data: success rates, by age of woman, fresh & frozen embryos from nondonor eggs, donor eggs, percent of clinics offering services by type.
Discussion/analysis of: type ART procedure used, pregnancy success rates, ART cycles using frozen embryos, ART cycles using donor eggs, ART cycles using nondonor eggs and embryos, success rates by women's age

Tables and analyses of 2015 report: National Summary

Total no. of ART procedures performed, % by type.
No. of infants born through ART
Percent multiple birth deliveries
Percent of ART transfers resulting in a pregnancy.
Age distribution of patients undergoing fresh IVF cycles: 2014

Text, analyses & discussion covering these topics: (long-term trend data)

How old were women who used ART?
How did the types of ART cycles performed differ by a woman's age?
How many frozen egg cycles were conducted and what were the outcomes of these cycles?
Why were some ART cycles canceled?
What percentage of ART cycles resulted in a pregnancy?
What percentage of ART pregnancies resulted in a live birth?
What percentage of ART cycles resulted in a multiple-fetus pregnancy or multiple-infant birth?
How did the percentage of ART cycles that resulted in pregnancies, live births, and births of single live infants differ among women aged 40 or older?
How did a woman's age affect ART cycle progress and outcomes?
How did previous birth impact ART live-birth outcomes?
How did previous unsuccessful ART use impact ART live-birth outcomes among women with no previous births?
Did the use of ICSI differ by age group or by male factor infertility diagnosis?
How many embryos were typically transferred in an ART procedure?
Did the number of embryos transferred impact the percentage of single, term, and normal birth weight infants born?
How long after egg retrieval did embryo transfer occur?
What percentage of ART cycles resulted in a multiple-fetus pregnancy or multiple-infant birth?
Was the use of donor eggs or embryos higher among older women undergoing ART?
What are egg/embryo banking cycles and have they increased?
Has the number of cycles using donor eggs or embryos increased?
Is the use of ART increasing? Is the use of ICSI increasing?
Have there been changes in the type of ART cycles performed among women who used fresh or frozen nondonor eggs or embryos?
Has the no. of embryos transferred in fresh non-donor cycles changed?
Has the no. of embryos transferred in each ART cycle changed?
Have there been improvements in ART success rates by no. of embryos transferred?
Has the % of multiple-infant live births changed?
Has the % of singletons, twins and triplets or more changed for ART cycles using fresh non-donor eggs or embryos?

12. Major Competitor Profiles

Summary: discussion of consolidation, how larger clinics are capturing greater share of the market

Tables:

Ranking of top 21 IVF clinics, by no. of cycles performed: 2006, 2010, 2011, 2014, 2016
Ranking of top 21 IVF clinics, by. no. of cycles performed and estd. revenues per clinic in 2016

Descriptions of activities, specialties, mission, revenues if available, address, for:

Resolve
Allan Guttmacher Institute
Genetics and IVF Institute
IntegraMed America, Inc.

Industry Reference Directory

List of adoption and fertility services industry trade groups, associations, surveys, consultants, and other sources.

For more information about this report visit https://www.researchandmarkets.com/research/5sk7kf/u_s_fertility?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets